Literature DB >> 1941144

Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.

Y Iida1, A Hidaka, H Hatabu, K Kasagi, J Konishi.   

Abstract

The utility of 201TI scintigraphy and thyroglobulin measurement in the follow-up observation of postoperative patients with thyroid cancer was evaluated. Thallium-201 scintigraphy was performed in 149 postoperative patients with thyroid cancer. Serum thyroglobulin concentration was concomitantly evaluated in 86 patients. Among 55 patients with positive 201TI scans, 51 patients (92.7%) had recurrent diseases, while 80 of 94 patients (85.1%) with negative scans were free of disease. Twenty-five of 28 patients (89.3%) with elevated thyroglobulin levels were recurrent and 43 of 58 patients (74.1%) with normal thyroglobulin level had no recurrence nor metastasis. All 19 patients with positive 201TI scans and elevated thyroglobulin level had recurrent lesions. Seven of 10 patients with negative 201TI scans and elevated thyroglobulin level showed the presence of metastasis. By concomitant measurement of serum thyroglobulin, more than half of the recurrent patients with negative 201TI scintigraphy were detected. Both 201TI scintigraphy and serum thyroglobulin measurement should be undertaken in the follow-up evaluation of postoperative patients with thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941144

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  2 in total

1.  Thallium-201 scintigraphy in the evaluation of thyroid nodules. A retrospective study of 246 cases.

Authors:  M Koizumi; H Taguchi; M Goto; T Nomura; T Watari
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

2.  Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.

Authors:  S Kosuda; H Yokoyama; M Katayama; T Yokokawa; S Kusano; O Yamamoto
Journal:  Eur J Nucl Med       Date:  1995-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.